chr1-53250747-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004631.5(LRP8):āc.2619A>Cā(p.Glu873Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004631.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRP8 | NM_004631.5 | c.2619A>C | p.Glu873Asp | missense_variant | 17/19 | ENST00000306052.12 | |
LRP8 | NM_001018054.3 | c.2619A>C | p.Glu873Asp | missense_variant | 17/18 | ||
LRP8 | NM_033300.4 | c.2109A>C | p.Glu703Asp | missense_variant | 15/17 | ||
LRP8 | NM_017522.5 | c.2007A>C | p.Glu669Asp | missense_variant | 15/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRP8 | ENST00000306052.12 | c.2619A>C | p.Glu873Asp | missense_variant | 17/19 | 1 | NM_004631.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251450Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135904
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461570Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727066
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152292Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2023 | The c.2619A>C (p.E873D) alteration is located in exon 17 (coding exon 17) of the LRP8 gene. This alteration results from a A to C substitution at nucleotide position 2619, causing the glutamic acid (E) at amino acid position 873 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at